SCHEMBL13829985

SCHEMBL13829985

COc1ccc2c(C)ncc(O)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.43
HPGD P15428 3/20 0.43
MEN1 O00255 3/20 0.43
TP53 P04637 1/20 0.43
TLR8 Q9NR97 1/20 0.43
ESR2 Q92731 1/20 0.42
KDM4E B2RXH2 5/20 0.41
ALDH1A1 P00352 5/20 0.41
HSD17B10 Q99714 4/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MAOA P21397 2/20 0.41
ACHE P22303 2/20 0.41
DYRK1A Q13627 2/20 0.41
DYRK3 O43781 1/20 0.41
CCNT1 O60563 1/20 0.41
CCNB2 O95067 1/20 0.41
CYP1A2 P05177 1/20 0.41
CDK1 P06493 1/20 0.41
CYP3A4 P08684 1/20 0.41
ADRA2A P08913 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13729538 0.83 DYRK1A (0.43) KMT2AHPGDMEN1TLR8ESR2
SCHEMBL24916401 0.78 P2RX3 (0.42) KMT2AHPGDMEN1KDM4EALDH1A1
SCHEMBL4656639 0.77 PDE10A (0.49) KMT2AMEN1KDM4EALDH1A1GAA
SCHEMBL10331766 0.75 ALDH1A1 (0.55) KMT2AHPGDMEN1TP53TLR8
SCHEMBL28660516 0.74 EGLN1 (0.47) ACHESLC6A2GAATHRBTDP1
SCHEMBL4813692 0.74 HSD17B10 (0.52) KMT2AHPGDMEN1KDM4EALDH1A1
SCHEMBL14543177 0.74 SMN1; SMN2 (0.53) KMT2AHPGDMEN1KDM4EALDH1A1
SCHEMBL1563993 0.71 IDO1 (0.46) HPGDKDM4EALDH1A1HSD17B10CYP1A2
SCHEMBL13652181 0.70 KDM4E (0.49) KMT2AHPGDMEN1KDM4EALDH1A1
Formic Acid SCHEMBL28482955 0.69 EGLN1 (0.46) ACHESLC6A2GAATHRBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012151195-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-11-08 WO disclosed